Noradrenaline activity

Hirst I didn t make that statement. I said it didn t act as a post-junctional transmitter in a fine resistance artery. In the vein I would say that noradrenaline activates an a receptor and goes through an InsP3-dependent pathway. If you look physiologically there are clear examples where internal stores are involved in neurotransmission. What I am saying is that the places where internal stores are present seem to me to exceed the physiological requirement for them. 

The loss of weight in this patient did not seem to be due her to psychiatric condition. The authors speculated that reboxetine might have some serotonergic activity, which could have accounted for a reduction in appetite and concomitant weight loss. However, drugs that potentiate noradrenaline activity can also reduce hunger, so this adverse effect could be due to the well characterized noradrenergic effects of reboxetine. 

The serotonin syndrome can present with hypomanic features, and the clinical picture and rapid onset in this case suggested that the addition of sibutramine to citalopram provoked serotonin toxicity. Sibutramine blocks the reuptake of serotonin, dopamine, and noradrenaline. Whether the serotonin toxicity seen here resulted purely from the combined effects of both citalopram and sibutramine in blocking serotonin re-uptake is unclear. It is possible, for example, that potentiation of dopamine and noradrenaline activity by sibutramine might also have been involved. 

The catecholamines - dopamine, norepinephrine, and epinephrine are successively derived from tyrosine. S m-thesis occurs in the nerve terminals and in the adrenal gland. Tyrosine hydroxylase catalyzes the first step (Figure 10.2a) and is the major site of regulation (inhibition by dopamine and noradrenaline, activation by cAMP). This step gives rise to 3,4-dihydroxyphenylalanine (L-DOPA), which in turn is a substrate for L-aromatic acid decarboxylase. De-... 

C. It is secreted along with noradrenaline by the adrenal medulla, from which it may be obtained. It may be synthesized from catechol. It is used as the acid tartrate in the treatment of allergic reactions and circulatory collapse. It is included in some local anaesthetic injections in order to constrict blood vessels locally and slow the disappearance of anaesthetic from the site of injection. Ultimately it induces cellular activation of phosphorylase which promotes catabolism of glycogen to glucose. 

Fig. 10. The postulated interaction of a-adrenoceptor agonists with the receptor. The Easson-Stedman hypothesis suggests that (R)-noradrenaline is most potent owing to its three points of attachment () to the adrenoceptor, whereas dopamine and (5)-noradrenaline are equal in activity, but less active...

Other agents are also used for the treatment of manic-depressive disorders based on preliminary clinical results (177). The antiepileptic carbamazepine [298-46-4] has been reported in some clinical studies to be therapeutically beneficial in mild-to-moderate manic depression. Carbamazepine treatment is used especially in bipolar patients intolerant to lithium or nonresponders. A majority of Hthium-resistant, rapidly cycling manic-depressive patients were reported in one study to improve on carbamazepine (178). Carbamazepine blocks noradrenaline reuptake and inhibits noradrenaline exocytosis. The main adverse events are those found commonly with antiepileptics, ie, vigilance problems, nystagmus, ataxia, and anemia, in addition to nausea, diarrhea, or constipation. Carbamazepine can be used in combination with lithium. Several clinical studies report that the calcium channel blocker verapamil [52-53-9] registered for angina pectoris and supraventricular arrhythmias, may also be effective in the treatment of acute mania. Its use as a mood stabilizer may be unrelated to its calcium-blocking properties. Verapamil also decreases the activity of several neurotransmitters. Severe manic depression is often treated with antipsychotics or benzodiazepine anxiolytics. 

Kenakin, T. P. (1984). The relative contribution of affinity and efficacy to agonist activity Organ selectivity of noradrenaline and oxymetazoline. Br. J. Pharmacol. 81 131—141. 

Hi-receptors in the adrenal medulla stimulates the release of the two catecholamines noradrenaline and adrenaline as well as enkephalins. In the heart, histamine produces negative inotropic effects via Hr receptor stimulation, but these are normally masked by the positive effects of H2-receptor stimulation on heart rate and force of contraction. Histamine Hi-receptors are widely distributed in human brain and highest densities are found in neocortex, hippocampus, nucleus accumbens, thalamus and posterior hypothalamus where they predominantly excite neuronal activity. Histamine Hrreceptor stimulation can also activate peripheral sensory nerve endings leading to itching and a surrounding vasodilatation ( flare ) due to an axonal reflex and the consequent release of peptide neurotransmitters from collateral nerve endings. 

Sympatholytic drugs are a group of drugs, which decrease the activity of the sympathetic nervous system, mainly by blocking the action of adrenaline and noradrenaline at adrenoceptors. 

There are numerous transmitter substances. They include the amino acids glutamate, GABA and glycine acetylcholine the monoamines dopamine, noradrenaline and serotonin the neuropeptides ATP and NO. Many neurones use not a single transmitter but two or even more, a phenomenon called cotransmission. Chemical synaptic transmission hence is diversified. The basic steps, however, are similar across all neurones, irrespective of their transmitter, with the exception of NO transmitter production and vesicular storage transmitter release postsynaptic receptor activation and transmitter inactivation. Figure 1 shows an overview. Nitrergic transmission, i.e. transmission by NO, differs from transmission by other transmitters and is not covered in this essay. 

In smooth muscle, by contrast, one sympathetic nerve fibre can influence a number of muscle fibres by releasing noradrenaline from varicosities along its length without there being any defined end-plate junctions. The result of receptor activation is a slow change in potential and inactivation of the NT is initially by uptake and then metabolism. In other words, the NT function is geared to the slower phasic changes in tone characteristic of smooth muscle. 

---